top of page

How to set up an employer STI testing program with at-home kits

Nov 10
5 min read
Flat illustration of an office benefits area blending into a lab, with an at-home test kit, specimen tubes and a laptop showing a privacy shield, in navy, lavender and pink

An employer STI testing program works best when participation is voluntary, kits ship discreetly to employees' homes, a licensed clinician orders the tests, and results go only to the employee and that clinician. The employer funds and promotes the benefit but sees only aggregate participation data, never individual results.


That one sentence covers most of the design. The rest of this guide walks HR, benefits and people-operations leads through the questions that come up when an organization adds at-home STI testing: privacy, who orders the tests, what to offer, logistics, follow-up care and how to compare vendors.


It's educational only, not legal or medical advice. Bring your benefits counsel in early.



Start with privacy, not the test menu


Employees will only use a sexual health benefit they trust. Build the program so that no one at the company can connect a person to a result.



Keep participation voluntary


The EEOC's enforcement guidance on disability-related inquiries and medical examinations says employers may offer voluntary medical exams as part of a wellness program. A program counts as voluntary when the employer neither requires participation nor penalizes employees who don't take part. The same guidance says medical records from these programs must be kept confidential and separate from personnel records.


If you plan to attach incentives or run the program through your health plan, review the current rules with counsel before launch.



Keep individual results away from the employer


HHS notes that the HIPAA Privacy Rule controls how a health plan or covered provider shares health information with an employer, and that a provider generally can't give an employer a patient's information without the patient's authorization. HHS also notes that the Privacy Rule doesn't protect employment records and, in most cases, doesn't apply to the actions of an employer. Your program design and contracts have to do the rest.


In practice:


  • Employees register kits directly with the lab or clinician platform, not through an HR system

  • Results go to the employee and the ordering clinician only

  • The employer receives de-identified, aggregate reports, such as kits shipped, kits returned and participation rate

  • Small groups are suppressed so no one can be identified by elimination

  • Contracts state that individual results will never be shared with the employer



Who orders the tests?


Lab tests are ordered by an authorized clinician, and the employer shouldn't be anywhere near that role. Most programs use one of three models:


  • A telehealth clinician partner reviews a short intake, orders the tests and handles results and treatment

  • An onsite or near-site clinic already serving your employees

  • The employee's own provider, which works for some, but makes follow-up harder to track


The ordering clinician has to be licensed in each state where employees live. If your workforce is spread out, confirm the clinician group's state coverage before you pick a test menu.



Which tests to offer


Let clinical guidance drive the menu rather than an all-in panel for everyone. CDC's STI Treatment Guidelines, 2021 are still the current edition, and its screening recommendations vary by age, anatomy and risk. Key points for a workforce program:


  • HIV: CDC recommends that everyone ages 13 to 64 be tested at least once

  • Chlamydia and gonorrhea: annual screening for sexually active women under 25, and for older women at increased risk

  • Gay, bisexual and other men who have sex with men: at least annual syphilis, chlamydia, gonorrhea and HIV testing, and every 3 to 6 months for those at higher risk

  • Hepatitis C: screening for all adults, except in very low-prevalence settings

  • Site of exposure matters: chlamydia and gonorrhea testing may need throat and rectal swabs, not only urine


A practical approach is a core kit plus clinician-guided add-ons. The intake questionnaire, reviewed by the clinician rather than the employer, decides who gets 3-site swabs or extra blood tests. For a deeper look at multi-site kits, see our 3-site STI test kit planning guide.



Sample types and kit logistics


CDC's Getting Tested for STIs page notes that STI tests may need blood, urine or swabs, and that people can self-collect and mail specimens to a lab. Plan the kit around those sample types:


  • Urine and self-collected swabs (vaginal, throat, rectal) for chlamydia, gonorrhea and trichomoniasis

  • Blood for HIV, syphilis and hepatitis tests. Ask your lab which blood collection methods it has validated for each test, and whether any test needs a draw at a collection site


Logistics questions to settle early:


  • Shipping address: send kits to homes in plain packaging, not to the office

  • Ordering windows: an open enrollment period or a year-round benefit

  • Return shipping: prepaid mailers, plus clear instructions on collection days and cutoff times

  • Rejected specimens: who contacts the employee, and how a replacement kit is sent

  • State coverage: where the lab can accept specimens and where the clinician can practice



Follow-up and treatment pathways


Testing without a care pathway can leave employees on their own with a positive result. Before launch, confirm:


  • Who calls the employee about a positive result, and how quickly

  • How prescriptions are written and filled

  • Whether the clinician offers expedited partner therapy, which CDC describes as an option for partners of patients with chlamydia or gonorrhea, where state law allows

  • How retesting works. CDC recommends retesting about 3 months after treatment for chlamydia and gonorrhea

  • Referrals for HIV care or PrEP when results or risk call for it


For a closer look at the lab side of PrEP and STI monitoring, see our PrEP and STI lab testing page.



What aggregate reporting should look like


Aggregate reports help you judge whether the benefit is used and worth renewing, without exposing anyone. Reasonable metrics include:


  1. Kits ordered and shipped

  2. Kits returned and the return rate

  3. Specimen rejection rate

  4. Participation by location or quarter, with small groups suppressed

  5. Employee satisfaction survey results


Positivity rates are best left out of employer reports unless counsel and the clinical partner agree they can be shared safely. With small groups, they can point to individuals.



How to evaluate vendors


Use the same questions for each vendor so answers are easy to compare:


  • Is testing done in a CLIA-certified lab, and which state licenses does it hold?

  • Who is the ordering clinician, and which states do they cover?

  • How do results reach the employee, and can the employer ever see them?

  • What's in the aggregate report, and how are small groups handled?

  • Which sample types are validated for each test?

  • What happens after a positive result?

  • Can kits carry your organization's or benefit partner's brand? Our white-label test kits page shows how that usually works.

  • What's the typical turnaround after the lab receives a specimen? Many labs quote 24 to 72 hours for routine tests


For reference, IHDLab is a CLIA-certified (05D2040304), over 51% LGBTQ+-owned lab licensed in California, New York and Maryland. It works B2B only and ships at-home kits to all 50 states.



Bringing it together


A successful employer STI testing program is mostly about trust. Keep it voluntary, route results only to employees and their clinician, give leadership aggregate numbers, and make sure every positive result leads to care. If you're building one and want to compare lab options, we're happy to talk it through.

bottom of page